Aetiology of type 2 diabetes in people with a 'normal’ body mass index: testing the personal fat threshold hypothesis
Open accessThe DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
Weight loss in overweight or obese individuals with Type 2 diabetes (T2D) can normalize hepatic fat metabolism, decrease fatty acid oversupply to β cells and restore normoglycaemia. One in six people has BMI <27 kg/m2 at diagnosis, and their T2D is assumed to have different aetiology. The Personal Fat Threshold hypothesis postulated differing individual thresholds for lipid overspill and adverse effects on β-cell function. To test this hypothesis, people with Type 2 diabetes and body mass index <27kg/m2 (n = 20) underwent repeated 5% weight loss cycles. Metabolic assessments were carried out at stable weight after each cycle and after 12 months. To determine how closely metabolic features returned to normal, 20 matched normoglycemic controls were studied once. Between baseline and 12 months: BMI fell (mean ± SD), 24.8 ± 0.4 to 22.5 ± 0.4 kg/m2 (P<0.0001) (controls: 21.5 ± 0.5); total body fat, 32.1 ± 1.5 to 27.6 ± 1.8% (P<0.0001) (24.6 ± 1.5). Liver fat content and fat export fell to normal as did fasting plasma insulin. Post-meal insulin secretion increased but remained subnormal. Sustained diabetes remission (HbA1c < 48 mmol/mol off all glucose-lowering agents) was achieved by 70% (14/20) by initial weight loss of 6.5 (5.5–10.2)%. Correction of concealed excess intra-hepatic fat reduced hepatic fat export, with recovery of β-cell function, glycaemic improvement in all and return to a non-diabetic metabolic state in the majority of this group with BMI <27 kg/m2 as previously demonstrated for overweight or obese groups. The data confirm the Personal Fat Threshold hypothesis: aetiology of Type 2 diabetes does not depend on BMI. This pathophysiological insight has major implications for management.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The risk of type 2 diabetes rises with BMI over 23 kg/m² in people of European origin, 32 or at lower BMI with Asian ancestry, 33 with increased liver and pancreas fat, even at BMI levels below 25 kg/m²”
From 5-year follow-up of the randomised Diabetes Remission Clinical Trial (DiRECT) of continued support for weight loss maintenance in the UK: an extension study (2024) · cites this paper as [32]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global aetiology and epidemiology of type 2 diabetes mellitus and its complications
Zheng, Y., Ley, S. H., & Hu, F. B. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.151 · Cited by 5,697 · cited 1×
“Hence, the nature of T2D itself has been overlooked, and concepts of heterogeneity of aetiology in different weight groups have emerged [54].”
Lean, M. E., Leslie, W. S., Barnes, A. C., Brosnahan, N., Thom, G., McCombie, L., Peters, C., Zhyzhneuskaya, S., Al-Mrabeh, A., Hollingsworth, K. G., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)33102-1 · Cited by 2,095 · cited 1×
“The stepwise induction of weight loss in the T2D group identified that the BMI threshold for return to non-diabetic HbA 1c values was crossed at a median of 23.1 kg/m 2 with a median 6.5% weight loss, less than the 9.9% weight loss required for the higher-BMI group studied in DiRECT [23].”
InfluentialSelf-citationSzczepaniak, L. S., Nurenberg, P., Leonard, D., Browning, J. D., Reingold, J. S., Grundy, S., Hobbs, H. H., & Dobbins, R. L. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00064.2004 · Cited by 1,562 · cited 1×
“Although liver fat content at baseline in the present study was within the usually accepted normal range derived from the Dallas Heart Study with mean BMI 30kg/m 2 [24], it is important to consider what is normal for people with lower BMI values.”
McGarry, J. D. (2002) · Diabetes · doi:10.2337/diabetes.51.1.7 · Cited by 1,435 · cited 1×
“The fat overflow hypothesis and separately the concept that chronic excess fatty acid exposure could impair β -cell function are far from new [35–39].”
Pancreatic β Cell Dedifferentiation as a Mechanism of Diabetic β Cell Failure
Talchai, C., Xuan, S., Lin, H. V., Sussel, L., & Accili, D. (2012) · Cell · doi:10.1016/j.cell.2012.07.029 · Cited by 1,415
Lim, E. L., Hollingsworth, K. G., Aribisala, B. S., Chen, M. J., Mathers, J. C., & Taylor, R. (2011) · Diabetologia · doi:10.1007/s00125-011-2204-7 · Cited by 1,164
Self-citationLipotoxicity in the Pathogenesis of Obesity-Dependent NIDDM: Genetic and Clinical Implications
Unger, R. H. (1995) · Diabetes · doi:10.2337/diab.44.8.863 · Cited by 1,100
Petersen, K. F., Dufour, S., Befroy, D., Lehrke, M., Hendler, R. E., & Shulman, G. I. (2005) · Diabetes · doi:10.2337/diabetes.54.3.603 · Cited by 911 · cited 1×
“The return to normal levels of liver fat after dietary weight loss in T2D, first demonstrated by Petersen and colleagues [17], emphasises the tight relationship between liver fat content, hepatic insulin sensitivity and restraint of hepatic glucose output by insulin [18–20].”
The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments
Targher, G., Corey, K. E., Byrne, C. D., & Roden, M. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00448-y · Cited by 850
Lee, Y., Hirose, H., Ohneda, M., Johnson, J. H., McGarry, J. D., & Unger, R. H. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.10878 · Cited by 836 · cited 1×
“Onset of T2D is likely to relate primarily to the β -cell functional insulin secretory capacity [31], confirmed in studies of remission and recurrence with weight regain in people with wide range of T2D duration [5,21,32].”
Endoplasmic reticulum stress contributes to beta cell apoptosis in type 2 diabetes
Laybutt, D. R., Preston, A. M., Åkerfeldt, M. C., Kench, J. G., Busch, A. K., Biankin, A. V., & Biden, T. J. (2007) · Diabetologia · doi:10.1007/s00125-006-0590-z · Cited by 830 · cited 1×
“The fat overflow hypothesis and separately the concept that chronic excess fatty acid exposure could impair β -cell function are far from new [35–39].”
Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease
Smith, G. I., Shankaran, M., Yoshino, M., Schweitzer, G. G., Chondronikola, M., Beals, J. W., Okunade, A. L., Patterson, B. W., Nyangau, E., Field, T., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci134165 · Cited by 771 · cited 1×
“The > 50% decrease in plasma triglycerides containing predominantly palmitic acid reflects decreased fasting de novo lipogenesis [13], as previously documented with weight loss in heavier people [4,5,21,28].”
EPIC-InterAct Consortium, Lotta, L. A., Cambridge FPLD1 Consortium, Gulati, P., Day, F. R., Payne, F., Ongen, H., van de Bunt, M., Gaulton, K. J., Eicher, J. D., et al. (2017) · Nature Genetics · doi:10.1038/ng.3714 · Cited by 585 · cited 1×
“The genetic basis of heterogeneity in subcutaneous fat storage capacity itself has been confirmed [50].”
Evidence of β-Cell Dedifferentiation in Human Type 2 Diabetes
Cinti, F., Bouchi, R., Kim-Muller, J. Y., Ohmura, Y., Sandoval, P. R., Masini, M., Marselli, L., Suleiman, M., Ratner, L. E., Marchetti, P., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2860 · Cited by 550
Consensus report: definition and interpretation of remission in type 2 diabetes
Riddle, M. C., Cefalu, W. T., Evans, P. H., Gerstein, H. C., Nauck, M. A., Oh, W. K., Rothberg, A. E., le Roux, C. W., Rubino, F., Schauer, P., et al. (2021) · Diabetes Care · doi:10.2337/dci21-0034 · Cited by 464
Self-citationLuukkonen, P. K., Zhou, Y., Sädevirta, S., Leivonen, M., Arola, J., Orešič, M., Hyötyläinen, T., & Yki-Järvinen, H. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.01.002 · Cited by 461 · cited 2×
“The proximal mediators of hepatic insulin resistance are the toxic lipid intermediaries (including ceramides and diacylglycerol) rather than stored triglyceride itself [26], and the former would be expected to fall more rapidly on initiation of negative energy balance.”
Taylor, R., Al-Mrabeh, A., Zhyzhneuskaya, S., Peters, C., Barnes, A. C., Aribisala, B. S., Hollingsworth, K. G., Mathers, J. C., Sattar, N., & Lean, M. E. J. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.07.003 · Cited by 450
Self-citationSteven, S., Hollingsworth, K. G., Al-Mrabeh, A., Avery, L., Aribisala, B., Caslake, M., & Taylor, R. (2016) · Diabetes Care · doi:10.2337/dc15-1942 · Cited by 418
Self-citationPancreatic β Cell Dedifferentiation in Diabetes and Redifferentiation following Insulin Therapy
Wang, Z., York, N. W., Nichols, C. G., & Remedi, M. S. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.03.010 · Cited by 406
Taheri, S., Zaghloul, H., Chagoury, O., Elhadad, S., Ahmed, S. H., El Khatib, N., Amona, R. A., El Nahas, K., Suleiman, N., Alnaama, A., et al. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30117-0 · Cited by 393 · cited 1×
“Remission of T2D after weight loss has been documented in all ethnicities tested [58–61], although it would be expected that different ethnicities will have different personal fat thresholds.”
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388 · cited 1×
“Onset of T2D is likely to relate primarily to the β -cell functional insulin secretory capacity [31], confirmed in studies of remission and recurrence with weight regain in people with wide range of T2D duration [5,21,32].”
Self-citationGlucolipotoxicity of the pancreatic beta cell
Poitout, V., Amyot, J., Semache, M., Zarrouki, B., Hagman, D., & Fontés, G. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.08.006 · Cited by 382 · cited 1×
“The development of hyperglycaemia will add to this β -cell metabolic insult, contributing to the well-recognised longer-term deterioration in glycaemic control [41].”
Pathogenesis of type 2 diabetes: tracing the reverse route from cure to cause
Taylor, R. (2008) · Diabetologia · doi:10.1007/s00125-008-1116-7 · Cited by 352 · cited 1×
“The Counterpoint study was designed to test the specific predictions of the Twin Cycle Hypothesis [27] that T2D was caused by excess fat inside liver and supplied to the β cells and that this the underlying mechanisms could be reversed to normal by weight loss, and hence the present study provides…”
Self-citationType 2 Diabetes in Adults: Management
Internal Clinical Guidelines Team (2015) · Cited by 296
Reversible changes in pancreatic islet structure and function produced by elevated blood glucose
Brereton, M. F., Iberl, M., Shimomura, K., Zhang, Q., Adriaenssens, A. E., Proks, P., Spiliotis, I. I., Dace, W., Mattis, K. K., Ramracheya, R., et al. (2014) · Nature Communications · doi:10.1038/ncomms5639 · Cited by 259 · cited 1×
“De-differentiation and loss of specialised function of β cells is consistent with recent studies [42–45] and re-differentiation would explain the observed recovery when endoplasmic reticulum stress is removed [42,43,45–47].”
Cnop, M., Abdulkarim, B., Bottu, G., Cunha, D. A., Igoillo-Esteve, M., Masini, M., Turatsinze, J.-V., Griebel, T., Villate, O., Santin, I., et al. (2014) · Diabetes · doi:10.2337/db13-1383 · Cited by 250 · cited 1×
“The metabolic stress of chronic nutrient oversupply in vitro is particularly evident following exposure to palmitate, [33], the product of de novo lipogenesis which is markedly increased in states of muscle insulin resistance [34].”
Pancreatic Ectopic Fat Is Characterized by Adipocyte Infiltration and Altered Lipid Composition
Pinnick, K. E., Collins, S. C., Londos, C., Gauguier, D., Clark, A., & Fielding, B. A. (2008) · Obesity · doi:10.1038/oby.2007.110 · Cited by 226
Cobelli, C., Dalla Man, C., Toffolo, G., Basu, R., Vella, A., & Rizza, R. (2014) · Diabetes · doi:10.2337/db13-1198 · Cited by 216 · cited 1×
“Indices of insulin sensitivity (SI) and insulin secretion normalised to insulin sensitivity (DI) were estimated by mathematical modelling [15] after a standard meal of ordinary foodstuffs (587 kcal; 65% carbohydrate, 13% protein and 19% fat) following an overnight fast.”
Self-citationReaven, G. M., Chen, Y. D., Hollenbeck, C. B., Sheu, W. H., Ostrega, D., & Polonsky, K. S. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.1.8421101 · Cited by 214 · cited 1×
“However, when appropriate BMI-matched controls are used, there is no difference in these parameters between non-obese and obese people [56] and the β -cell response after test meals is similar in non-obese and obese T2D groups [57].”
Worsening to diabetes in men with impaired glucose tolerance (?borderline diabetes?)
Jarrett, R. J., Keen, H., Fuller, J. H., & McCartney, M. (1979) · Diabetologia · doi:10.1007/bf00423146 · Cited by 201 · cited 1×
“When recruitment for UKPDS commenced in the 1970’s, 64% of the background population had a BMI less than 25 kg/m 2 [51] and the apparent lack of association of T2D with obesity at that time [52] is explicable by the small numbers of people with high BMI.”
Determinants of diabetes remission and glycemic control after bariatric surgery
Panunzi, S., Carlsson, L., De Gaetano, A., Peltonen, M., Rice, T., Sjöström, L., Mingrone, G., & Dixon, J. B. (2016) · Diabetes Care · doi:10.2337/dc15-0575 · Cited by 198 · cited 1×
“There is no proof that de-differentiation is the sole process underlying β -cell dysfunction, but if the state of metabolic stress persists too long, irreversible loss of endocrine function results [5,49].”
Normal weight individuals who develop Type 2 diabetes: the personal fat threshold
Taylor, R., & Holman, R. R. (2015) · Clinical Science · doi:10.1042/cs20140553 · Cited by 190
Self-citationFoster, E., Lee, C. M., Imamura, F., Hollidge, S. E., Westgate, K. L., Venables, M., Poliakov, I., Rowland, M. K., Osadchiy, T., Bradley, J., et al. (2019) · Journal of Nutritional Science · doi:10.1017/jns.2019.20 · Cited by 177 · cited 1×
“Diary-based total dietary intake over 3-day periods were evaluated using Intake 24 [11] during the 2 weeks prior to each study visit (baseline, 8, 16, 24 and 52 weeks).”
Steven (2016) · doi:10.2337/dc15-0750 · Cited by 171
Seppala-Lindroos, A. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.7.3023 · Cited by 168
Flannery, C., Dufour, S., Rabøl, R., Shulman, G. I., & Petersen, K. F. (2012) · Diabetes · doi:10.2337/db12-0206 · Cited by 168 · cited 1×
“The metabolic stress of chronic nutrient oversupply in vitro is particularly evident following exposure to palmitate, [33], the product of de novo lipogenesis which is markedly increased in states of muscle insulin resistance [34].”
Liver‐Fat Accumulation and Insulin Resistance in Obese Women with Previous Gestational Diabetes
Tiikkainen, M., Tamminen, M., Häkkinen, A., Bergholm, R., Vehkavaara, S., Halavaara, J., Teramo, K., Rissanen, A., & Yki‐Järvinen, H. (2002) · Obesity Research · doi:10.1038/oby.2002.118 · Cited by 162
Hepatic Lipoprotein Export and Remission of Human Type 2 Diabetes after Weight Loss
Al-Mrabeh, A., Zhyzhneuskaya, S. V., Peters, C., Barnes, A. C., Melhem, S., Jesuthasan, A., Aribisala, B., Hollingsworth, K. G., Lietz, G., Mathers, J. C., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2019.11.018 · Cited by 162 · cited 6×
“The present and previous studies show that the majority of people presenting with T2D are heavier than their individual metabolism can tolerate [4,5,21,22].”
InfluentialSelf-citationJones, A. G., McDonald, T. J., Shields, B. M., Hagopian, W., & Hattersley, A. T. (2021) · Diabetes Care · doi:10.2337/dc20-2834 · Cited by 122 · cited 1×
“Screening was carried out for monogenic diabetes (www.diabetesgenes.org) and islet cell antibodies (GAD (U/ml, positive > 10.9), human islet cell IA2 (U/ml, positive > 7.49) or ZnT8 (U/ml, positive > 9.99)) in the UK national test centre [8].”
InfluentialSanders, F. W. B., Acharjee, A., Walker, C., Marney, L., Roberts, L. D., Imamura, F., Jenkins, B., Case, J., Ray, S., Virtue, S., et al. (2018) · Genome Biology · doi:10.1186/s13059-018-1439-8 · Cited by 114 · cited 2×
“The > 50% decrease in plasma triglycerides containing predominantly palmitic acid reflects decreased fasting de novo lipogenesis [13], as previously documented with weight loss in heavier people [4,5,21,28].”
Self-citationWhite, M. G., Marshall, H. L., Rigby, R., Huang, G. C., Amer, A., Booth, T., White, S., & Shaw, J. A. M. (2013) · Diabetes Care · doi:10.2337/dc13-0705 · Cited by 101 · cited 1×
“De-differentiation and loss of specialised function of β cells is consistent with recent studies [42–45] and re-differentiation would explain the observed recovery when endoplasmic reticulum stress is removed [42,43,45–47].”
Hollenbeck, C. B., Chen, Y. D. I., & Reaven, G. M. (1984) · Diabetes · doi:10.2337/diab.33.7.622 · Cited by 95 · cited 1×
“However, when appropriate BMI-matched controls are used, there is no difference in these parameters between non-obese and obese people [56] and the β -cell response after test meals is similar in non-obese and obese T2D groups [57].”
A survey of heights and weights of adults in Great Britain, 1980
Rosenbaum, S., Skinner, R. K., Knight, I. B., & Garrow, J. S. (1985) · Annals of Human Biology · doi:10.1080/03014468500007621 · Cited by 92 · cited 1×
“When recruitment for UKPDS commenced in the 1970’s, 64% of the background population had a BMI less than 25 kg/m 2 [51] and the apparent lack of association of T2D with obesity at that time [52] is explicable by the small numbers of people with high BMI.”
Vaag, A., & Lund, S. S. (2007) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h07-100 · Cited by 89
Ravikumar, B., Gerrard, J., Dalla Man, C., Firbank, M. J., Lane, A., English, P. T., Cobelli, C., & Taylor, R. (2008) · Diabetes · doi:10.2337/db07-1828 · Cited by 75
Self-citationGenetic and pharmacologic inhibition of ALDH1A3 as a treatment of β-cell failure
Son, J., Du, W. J., Esposito, M., Shariati, K., Ding, H., Kang, Y., & Accili, D. (2023) · Nature Communications · doi:10.1038/s41467-023-36315-4 · Cited by 72
Steven, S., Hollingsworth, K. G., Small, P. K., Woodcock, S. A., Pucci, A., Aribasala, B., Al‐Mrabeh, A., Batterham, R. L., & Taylor, R. (2016) · Diabetic Medicine · doi:10.1111/dme.13257 · Cited by 71 · cited 1×
“Our present and previous studies demonstrate that these factors act in a coordinated fashion to cause T2D, and that effective weight loss across BMI range leads to a lower rate of continuous fatty acid delivery from plasma triglycerides to β cells [4,5,22,40].”
Self-citationZhyzhneuskaya, S. V., Al-Mrabeh, A., Peters, C., Barnes, A., Aribisala, B., Hollingsworth, K. G., McConnachie, A., Sattar, N., Lean, M. E. J., & Taylor, R. (2020) · Diabetes Care · doi:10.2337/dc19-0371 · Cited by 70 · cited 1×
“Although functional β -cell mass has been shown to return completely to normal during 12 months of dietary weight loss-induced remission of T2D, first phase insulin secretion improves but does not normalise either in the present or previous studies [30].”
Self-citationRehackova, L., Araújo‐Soares, V., Adamson, A. J., Steven, S., Taylor, R., & Sniehotta, F. F. (2017) · Diabetic Medicine · doi:10.1111/dme.13426 · Cited by 69 · cited 1×
“…the possibility of achieving the necessary weight loss with diet may be doubted by many doctors, but the acceptability of the specific dietary approach has been confirmed [62] and its success in the wider population of people with T2D has led to a NHS England national programme for remission [63].”
Self-citationPinnick, K., Neville, M., Clark, A., & Fielding, B. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22445 · Cited by 55
The cytoprotective actions of long-chain mono-unsaturated fatty acids in pancreatic β-cells
Morgan, N. G., Dhayal, S., Diakogiannaki, E., & Welters, H. J. (2008) · Biochemical Society Transactions · doi:10.1042/bst0360905 · Cited by 54 · cited 1×
“Palmitic acid is the most potent fatty acid in suppressing β -cell function [29].”
Umphonsathien, M., Prutanopajai, P., Aiam‐O‐Ran, J., Thararoop, T., Karin, A., Kanjanapha, C., Jiamjarasrangsi, W., & Khovidhunkit, W. (2019) · Food Science & Nutrition · doi:10.1002/fsn3.956 · Cited by 44 · cited 1×
“Remission of T2D after weight loss has been documented in all ethnicities tested [58–61], although it would be expected that different ethnicities will have different personal fat thresholds.”
Sarathi, V., Kolly, A., Chaithanya, H., & Dwarakanath, C. (2017) · Journal of Natural Science, Biology and Medicine · doi:10.4103/0976-9668.198343 · Cited by 39
Bynoe, K., Unwin, N. C., Taylor, C. G., Murphy, M. M., Bartholomew, L., Greenidge, A., Abed, M. T., Jeyaseelan, S. M., Cobelli, C., Man, C. D., et al. (2019) · Diabetic Medicine · doi:10.1111/dme.14096 · Cited by 38
Self-citationJenkins, B., Ronis, M. J. J., & Koulman, A. (2020) · Metabolites · doi:10.3390/metabo10070296 · Cited by 36 · cited 1×
“Concentration of plasma triglyceride 48:1 and 50:1 were used as best estimates of rate of fasting de novo lipogenesis [13] measured by liquid chromatography hyphenated with high-resolution mass spectrometry detection (LC-MS) [14].”
Self-citationPetersen, K. F., Dufour, S., Li, F., Rothman, D. L., & Shulman, G. I. (2022) · JCI Insight · doi:10.1172/jci.insight.157906 · Cited by 32 · cited 1×
“Consistent with this, Petersen and colleagues have observed the 95% boundary for liver fat to be less than 2% in individuals with BMI under 25 kg/m 2 [25].”
Research works printed but not linked: 1
- White, 2013, Expression of mesenchymal and α-cell phenotypic markers in islet β-cells in recently diagnosed diabetes, Diabetes Care., 36, 3818, 10.2337/dc13-0705 · DOI · Paper page
Cited by
Lean, M. E., Leslie, W. S., Barnes, A. C., Brosnahan, N., Thom, G., McCombie, L., Kelly, T., Irvine, K., Peters, C., Zhyzhneuskaya, S., et al. (2024) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(23)00385-6 · Cited by 186
Self-citationNielsen, R. L., Monfeuga, T., Kitchen, R. R., Egerod, L., Leal, L. G., Schreyer, A. T. H., Gade, F. S., Sun, C., Helenius, M., Simonsen, L., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-46663-4 · Cited by 91
“This is possibly due to the presence of a personal fat threshold, as it has been seen that weight loss can lead to type 2 diabetes remission even in those who do not have obesity 20 .”
The Causal Role of Ectopic Fat Deposition in the Pathogenesis of Metabolic Syndrome
Janssen, J. A. M. J. L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413238 · Cited by 83
Valabhji, J., Gorton, T., Barron, E., Safazadeh, S., Earnshaw, F., Helm, C., Virr, M., Kernan, J., Crowe, S., Aveyard, P., et al. (2024) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00194-3 · Cited by 72
Self-citationJanssen, J. A. M. J. L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105488 · Cited by 253
“In addition, it has been suggested (but at the moment not documented by studies) that different ethnicities have different PFTs, and this may help to explain why the prevalence of diabetes substantially differs among ethnic groups [115,116].”
BackgroundMethod
Metadata
- Authors
- Taylor, R., Barnes, A. C., Hollingsworth, K. G., Irvine, K. M., Solovyova, A. S., Clark, L., Kelly, T., Martin-Ruiz, C., Romeres, D., Koulman, A., Meek, C. M., Jenkins, B., Cobelli, C., & Holman, R. R.
- Affiliations
- Newcastle University (GB)
- University of Virginia (US)
- University of Cambridge (GB)
- 5Wellcome Trust-MRC Institute of Metabolic Science, University of Cambridge, Box 289, Cambridge Biomedical Campus, Cambridge, U.K.
- University of Padua (IT)
- University of Oxford (GB)
- Corresponding author
- Taylor, Roy
- ORCID
- Venue
- Clinical Science
- Publisher
- Portland Press Ltd.
- Published
- 2023-08
- Volume
- 137
- Issue
- 16
- Pages
- 1333-1346
- ISSN
- 0143-5221 (ISSN-L)
- 1470-8736
- PMC
- PMC10472166
- OpenAlex
- W4385969638
- Cited by
- 71
- References
- 56
- Citations by year
- 2026: 16 · 2025: 24 · 2024: 31
- FWCI
- 14.57
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Clinical Science (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Apollo (University of Cambridge) (submittedVersion, cc-by)
- Newcastle University ePrints (Newcastle Univesity) (cc-by)
- Funders
- Diabetes UK (17/0005645)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- type 2 diabetes, normal body mass index, weight loss, diabetes remission, liver fat, beta-cell function, insulin secretion, total body fat
- MeSH terms
- Diabetes Mellitus, Type 2, Humans, Obesity, Weight Loss, Body Mass Index, Overweight
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.